Ann Rheum Dis

1. COHEN P, Ziff D, Lipsky PE
   Morris Ziff.
   Ann Rheum Dis. 2024;83:417-420.
   

   >> Share

   
   
2. WINTHROP KL, Mease P, Kerschbaumer A, Voll RE, et al
   Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023.
   Ann Rheum Dis. 2024;83:409-416.
   

   >> Share

   
   
3. MELOKHINA V, Paulshus Sundlisaeter N, Sexton J, Sundin U, et al
   Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC study.
   Ann Rheum Dis. 2024;83:540-541.
   

   >> Share

   
   

   
   Arthritis Res Ther

4. CHRIST L, Kissling S, Finckh A, Fisher BA, et al
   Concomitant Sjogren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort.
   Arthritis Res Ther. 2024;26:68.
   

   >> Share

   
   
5. CHANG L, Zheng Z, Zhou Y, Liu K, et al
   B cell receptor repertoire analysis in primary Sjogren's syndrome salivary glands identifies repertoire features associated with clinical activity.
   Arthritis Res Ther. 2024;26:62.
   

   >> Share

   
   

   
   Clin Exp Rheumatol

6. LEBEL N, Marie I, Grosjean J, Brevet P, et al
   Potential efficacy of T and B lymphocyte-targeted therapies on articular involvement of patients with rheumatoid arthritis and systemic sclerosis overlap syndrome. Results from a 2-centre series of 22 cases.
   Clin Exp Rheumatol. 2024.
   

   >> Share

   
   

   
   Clin Rheumatol

7. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
   Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
   Clin Rheumatol. 2024 Mar 15. doi: 10.1007/s10067-024-06907.
   

   >> Share

   
   
8. ATHANASSIOU P, Katsimbri P, Bounas A, Gazi S, et al
   Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational
   Clin Rheumatol. 2024 Mar 12. doi: 10.1007/s10067-024-06916.
   

   >> Share

   
   
9. OZ N, Gezer HH, Cilli Hayiroglu S, Duruoz MT, et al
   Evaluation of the prognostic nutritional index (PNI) as a tool for assessing disease activity in rheumatoid arthritis patients.
   Clin Rheumatol. 2024 Mar 11. doi: 10.1007/s10067-024-06927.
   

   >> Share

   
   

   
   Immunology

10. XUAN Y, Zhang X, Wu H
    Impact of sex differences on the clinical presentation, pathogenesis, treatment and prognosis of Sjogren's syndrome.
    Immunology. 2024;171:513-524.
    

    >> Share

    
    

    
    PLoS One

11. SHRESTHA DS, Manandhar S, Chalise BS, Rajbhandari SK, et al
    Symptoms 6 months following SARS-CoV-2 infection in Nepali women.
    PLoS One. 2024;19:e0299141.
    

    >> Share

    
    

    
    Rheumatol Int

12. BAY LT, Nielsen DS, Flurey C, Giraldi A, et al
    Associations of gender with sexual functioning, loneliness, depression, fatigue and physical function amongst patients suffering from rheumatoid arthritis with a particular focus on methotrexate usage.
    Rheumatol Int. 2024 Mar 14. doi: 10.1007/s00296-024-05555.
    

    >> Share

    
    
13. SANTOS CS, Chen JP, Nikiphorou E, Tseng CW, et al
    Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
    Rheumatol Int. 2024 Mar 12. doi: 10.1007/s00296-024-05542.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share